Supplementary Figure S5 from LP-184, a Novel Acylfulvene Molecule, Exhibits Anticancer Activity against Diverse Solid Tumors with Homologous Recombination Deficiency
Key Points
Key points are not available for this paper at this time.
Abstract
Figure S5 shows the in vivo tumor response in a TNBC PDX model to LP-184 in combination with Olaparib
AIに質問
Like
Bookmark
Share
View Full Paper
AIに質問
Like
Bookmark
Share
View Full Paper
Supplementary Figure S5 from LP-184, a Novel Acylfulvene Molecule, Exhibits Anticancer Activity against Diverse Solid Tumors with Homologous Recombination Deficiency | Synapse